NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Over the past seven years, as Steven K. Libutti was designing the 12-story, $900-plus million cancer hospital in New Brunswick, NJ, he often thought of the functionality of the building that inspired it: Building 10, the NIH Clinical Center.

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models.

April 25, 2025

Vol.51 No.16

By Claire Marie Porter

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

We are at a transformational period in oncology; the overall mortality from cancer is gradually declining in the United States.

April 25, 2025

Vol.51 No.16

By Suresh S. Ramalingam and Adam Marcus

Advancing peritoneal oncology: Innovations in surgical strategies and research

Peritoneal metastases arise from gastrointestinal and gynecologic malignancies, leading to debilitating symptoms and poor prognoses. They remain one of the most challenging manifestations of advanced malignancies, often leading to significant morbidity and limited treatment options.

DOGE implements manual review of awarded funds

The Department of Government Efficiency has started requiring HHS grantees to provide justifications in order to receive payouts for already awarded grant money.

NIH notice prohibits grant awardees from operating programs that promote DEI

NIH, in a recent notice, prohibits grant recipients from operating programs that promote DEI or “discriminatory equity ideology,” or engage in “discriminatory prohibited boycott.”

April 25, 2025

Vol.51 No.16

By Jacquelyn Cobb

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

YOU MAY BE INTERESTED IN

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

Advancing peritoneal oncology: Innovations in surgical strategies and research

DOGE implements manual review of awarded funds

NIH notice prohibits grant awardees from operating programs that promote DEI

Renew today!

Subscriber content

Never miss an issue!

Login

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

YOU MAY BE INTERESTED IN

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

Advancing peritoneal oncology: Innovations in surgical strategies and research

DOGE implements manual review of awarded funds

NIH notice prohibits grant awardees from operating programs that promote DEI

Never miss an issue!

Login

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas